Nine Ten Capital Management Lowers stake in Mesa Laboratories (MLAB)

Mesa Laboratories (MLAB) : Nine Ten Capital Management reduced its stake in Mesa Laboratories by 1.11% during the most recent quarter end. The investment management company now holds a total of 251,041 shares of Mesa Laboratories which is valued at $31,234,521 after selling 2,820 shares in Mesa Laboratories , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Mesa Laboratories makes up approximately 10.01% of Nine Ten Capital Management’s portfolio.

Other Hedge Funds, Including , Allianz Asset Management Ag boosted its stake in MLAB in the latest quarter, The investment management firm added 56 additional shares and now holds a total of 27,268 shares of Mesa Laboratories which is valued at $3,392,685. Rpg Investment Advisory sold out all of its stake in MLAB during the most recent quarter. The investment firm sold 1,680 shares of MLAB which is valued $200,928.Kistler-tiffany Companies reduced its stake in MLAB by selling 3,000 shares or 11.41% in the most recent quarter. The Hedge Fund company now holds 23,301 shares of MLAB which is valued at $2,806,605. Mesa Laboratories makes up approx 1.41% of Kistler-tiffany Companies’s portfolio.Victory Capital Management Inc boosted its stake in MLAB in the latest quarter, The investment management firm added 17,197 additional shares and now holds a total of 159,422 shares of Mesa Laboratories which is valued at $19,093,973. Mesa Laboratories makes up approx 0.06% of Victory Capital Management Inc’s portfolio.Strs Ohio reduced its stake in MLAB by selling 1,000 shares or 25.0% in the most recent quarter. The Hedge Fund company now holds 3,000 shares of MLAB which is valued at $383,670.

Mesa Laboratories closed down -0.81 points or -0.61% at $131.29 with 33,848 shares getting traded on Monday. Post opening the session at $132, the shares hit an intraday low of $124.98 and an intraday high of $134.34 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

Investors should note that on Oct 4, 2016, Mesa Laboratories announced a cash dividend of $0.1600. The company’s management has announced Nov 28, 2016 as the ex-dividend date and fixed the record date on Nov 30, 2016. The payable date has been fixed on Dec 15, 2016.

Mesa Laboratories Inc. is primarily focused on quality control products. The Company has three segments: Instruments Biological Indicators and Continuous Monitoring. The Company’s Instruments segment designs manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare pharmaceutical food and beverage medical device industrial hygiene environmental air sampling and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes in the hospital dental medical device and pharmaceutical industries. Its Continuous Monitoring segment designs develops and markets systems which are used to monitor various environmental parameters in hospitals pharmaceutical and medical device manufacturers blood banks pharmacies and a number of other laboratory and industrial environments.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Mesa Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Mesa Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.